Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q3 2024 · 10-Q
Revenue$10.60B$10.60B+0.2% vs Q3 2023 Net Income$1.63B$1.63B−3.8% vs Q3 2023 EPS Diluted$4.25$4.25−3.8% vs Q3 2023 Operating Income$1,838,000,000−1.4% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$1,894,000,000−9.0% Margins · derivedOperating margin17.3%−0.3 pt vs Q3 2023
Net margin15.4%−0.6 pt vs Q3 2023
ended Sep 28, 2024 · filed Nov 1, 2024 · 34 d after period end